Shield Therapeutics PLC (LSE:STX) - Share price


Stock Report

Shield Therapeutics PLC STX

Last Price
GBX113.00

Day Change
-0.50|-0.44%

As of 24/06/2019
13:35:46 BST | GBX
Minimum 15 Minutes Delay.

Last Close113.50p
Day Range112.00 - 115.00
Mkt Cap132.90Mil
52-Wk Range27.00 - 122.25
Yield %-
ISINGB00BYV81293
Volume37,568
P/E-56.50
P/S0.11
P/CF-7.39

Share Price

Total Returns 24/06/2019

 Chg (%)  
More ...
Shield Therapeutics PLC0.44 
FTSE 100 TR GBP2.18
 
Financials
201620172018
More ...
Income Statement
Turnover0.300.6411.88
Operating Profit-12.46-20.95-5.17
Net Profit-15.02-19.59-1.79
Reported EPS-15.00-17.00-2.00
Balance Sheet
Current Assets23.3815.0012.42
Non Current Assets29.0029.9730.97
Total Assets52.3844.9743.38
Current Liabilities3.993.762.95
Total Liabilities---
Total Equity48.4041.2140.43
Cash Flow
Operating Cash Flow-10.26-18.14-2.04
Net Change in Cash20.25-7.68-3.52
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
25/04/2019Exercise of OptionMr. Carl Andrew Sterritt1.50123,6901,855.00
16/04/2019PurchaseJames Michael Karis81.004,0003,240.00
15/04/2019PurchaseJames Michael Karis81.5046,00037,490.00
21/09/2018PurchaseMr. Carl Andrew Sterritt34.0088,23530,000.00

Company Profile

Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 19/09/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-12.69
Op Mrgn-0.44
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanJames Michael Karis
Non-Executive DirectorMr. Peter Hermann William Llewellyn-Davies
Executive Director, Chief Executive OfficerMr. Carl Andrew Sterritt
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.